Liver Fibrosis and Cirrhosis

The Liver Fibrosis and Cirrhosis SIG is an interactive group of investigators focusing on the pathogenesis, diagnosis and treatment of liver fibrosis and outcomes research. This SIG aims to broaden our knowledge of the disease and foster collaborations in basic and translational/clinical studies of liver fibrosis and cirrhosis with a strong focus on extracellular matrix and hepatic stellate cell biology, as well as antifibrotic treatments and trials. The Liver Fibrosis and Cirrhosis SIG sponsors programs at the AASLD Annual Meeting, identifies emerging topics in fibrosis and cirrhosis research, and develops educational webinar programs.

SIG Leadership

Chair
Heather L. Francis, PhD, FAASLD
Vice Chair
Meena B. Bansal, MD, FAASLD
Communication Lead
Marko Groeger, PhD
Education Lead
Tatiana Kisseleva, MD, PhD
Trainee Lead
Rabab Ali, MBBS
SIG Steering Committee Member
Gianfranco Alpini, PhD, FAASLD
Staff Liaisons
Akuender Dot, MPH
Julie Hoffman, MBA
At-Large
Leila Gobejishvili, PhD